Daniel D Burgess - Net Worth and Insider Trading
Daniel D Burgess Net Worth
The estimated net worth of Daniel D Burgess is at least $1,895 dollars as of 2024-04-27. Daniel D Burgess is the Director of Cidara Therapeutics Inc and owns about 150 shares of Cidara Therapeutics Inc (CDTX) stock worth over $1,895. Daniel D Burgess is also the Director of Nabriva Therapeutics PLC and owns about 415 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Daniel D Burgess's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel D Burgess has not made any transactions after 2022-08-02 and currently still holds the listed stock(s).
Transaction Summary of Daniel D Burgess
Daniel D Burgess Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel D Burgess owns 5 companies in total, including Nabriva Therapeutics PLC (NBRVF) , Cidara Therapeutics Inc (CDTX) , and Arbutus Biopharma Corp (ABUS) among others .
Click here to see the complete history of Daniel D Burgess’s form 4 insider trades.
Insider Ownership Summary of Daniel D Burgess
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | director |
| CDTX | Cidara Therapeutics Inc | 2020-06-25 | director |
| ABUS | Arbutus Biopharma Corp | 2017-03-23 | director |
| LGNZZ | Metabasis Therapeutics Inc | 2009-06-23 | director |
| HRBR | Harbor Diversified Inc | 2004-01-16 | COO/CFO |
Daniel D Burgess Latest Holdings Summary
Daniel D Burgess currently owns a total of 2 stocks. Among these stocks, Daniel D Burgess owns 150 shares of Cidara Therapeutics Inc (CDTX) as of April 20, 2015, with a value of $1,895 and a weighting of 100%. Daniel D Burgess also owns 415 shares of Nabriva Therapeutics PLC (NBRVF) as of August 2, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Daniel D Burgess
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2015-04-20 | 150 | 12.63 | 1,895 |
| NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | 415 | 0.00 | 0 |
Holding Weightings of Daniel D Burgess
Daniel D Burgess Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel D Burgess has made a total of 0 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years. The most-recent trade in Cidara Therapeutics Inc is the acquisition of 150 shares on April 20, 2015, which cost Daniel D Burgess around $48,000.
According to the SEC Form 4 filings, Daniel D Burgess has made a total of 2 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nabriva Therapeutics PLC is the sale of 454 shares on August 2, 2022, which brought Daniel D Burgess around $2,155.
Insider Trading History of Daniel D Burgess
- 1
Daniel D Burgess Trading Performance
GuruFocus tracks the stock performance after each of Daniel D Burgess's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel D Burgess is -14.62%. GuruFocus also compares Daniel D Burgess's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel D Burgess within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel D Burgess's insider trading performs compared to the benchmark.
Performance of Daniel D Burgess
Average Return
-10.1%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.33 | -14.62 | -16.26 | -10.1 | -41.39 | -51.09 |
| Relative Return to S&P 500(%) | -1.79 | -13.43 | -12.61 | -13.06 | -48.22 | -63.25 |
Daniel D Burgess Ownership Network
Ownership Network List of Daniel D Burgess
Ownership Network Relation of Daniel D Burgess
Daniel D Burgess Owned Company Details
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
Daniel D Burgess is the director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
Daniel D Burgess Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel D Burgess. You might contact Daniel D Burgess via mailing address: C/o Hollis-eden Pharmaceuticals, 4435 Eastgate Mall Ste.400, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
